-
EntrepreneurInfinityBit InfinityBit: A New Era of Transparent Trading
-
EntrepreneurRICOVR Rapid Saliva Testing For Biomarkers
-
EntrepreneurSmart Soda A new standard in wellness beverages for offices, c-stores, healthcare, education and restaurants.
-
EntrepreneurWibly Visual Learning Platform for Knowledge Networks
-
EntrepreneurSovány Beverage Sovany is more than just another organic sparkling water
-
EntrepreneurUbiq
-
EntrepreneurCommerceBlitz
-
Information
iCFO Information Booth How can we help? -
Entrepreneur
Arise BioPharma -
Entrepreneur
PerioSciences
Event DealConnect 360: The Ultimate Deal Room for Real Results! is over.
Join us next time to meet Jeff Galvin!
Join us next time to meet Jeff Galvin!
About Addimmune
Addimmune
Addimmune’s sole purpose is to cure HIV. We believe it’s possible with gene and cell therapy.
Available from
1:30 PM
-
4:00 PM
(US/Pacific)
+1 301-337-2108
Addimmune is a Rockville, Maryland-based, clinical-stage cell and gene therapy company with a line of sight on a functional HIV cure. We have completed a successful FDA-approved Phase I human clinical trial with no serious adverse events and have shown blood markers of efficacy in all seven treated trial participants. An IRB-approved treatment interruption protocol demonstrated the reconstitution of the immune systems of the six who consented to participate. A $50M capital raise is being undertaken in conjunction with 10X Capital, our Wall Street partners with whom we plan a public transaction via de-SPAC in Q1 of next year, to fund our next phase human clinical trial also to begin in Q1 of 2024.
